State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy

Christoph Schukro; David Santer; Günther Prenner; Markus Stühlinger; Martin Martinek; Alexander Teubl; Deddo Moertl; Stefan Schwarz; Michael Nürnberg; Lukas Fiedler; Robert Hatala; Cesar Khazen

doi:10.1002/clc.23432

State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy

Christoph Schukro, David Santer, Günther Prenner, Markus Stühlinger, Martin Martinek, Alexander Teubl, Deddo Moertl, Stefan Schwarz, Michael Nürnberg, Lukas Fiedler, Robert Hatala, Cesar Khazen

Division of Internal Medicine 3 (University Hospital St. Pölten)

Research output: Journal article (peer-reviewed) › Review article

5 Citations (Scopus)

Abstract

Within the last decade, implantable cardioverter-defibrillator (ICD) systems with non-transvenous leads were developed in order to minimize complications related to the cardiovascular position of transvenous ICD leads. This national expert consensus gives an overview of potential indications for the implantation of non-transvenous ICD systems, and provides specific recommendations for implantation, follow-up, and complication management in patients with subcutaneous ICD. Regarding particular issues like the necessity for shock efficacy testing, or the clinical outcome as compared to transvenous ICD, randomized data are expected in the near future.

Original language	English
Pages (from-to)	1084-1092
Number of pages	9
Journal	Clinical Cardiology
Volume	43
Issue number	10
DOIs	https://doi.org/10.1002/clc.23432
Publication status	Published - 01 Oct 2020

Keywords

Consensus
Death, Sudden, Cardiac/prevention & control
Defibrillators, Implantable
Humans

Access to Document

10.1002/clc.23432

Cite this

@article{195ee8b7169b4f3e819caded6bdbcbb6,

title = "State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy",

abstract = "Within the last decade, implantable cardioverter-defibrillator (ICD) systems with non-transvenous leads were developed in order to minimize complications related to the cardiovascular position of transvenous ICD leads. This national expert consensus gives an overview of potential indications for the implantation of non-transvenous ICD systems, and provides specific recommendations for implantation, follow-up, and complication management in patients with subcutaneous ICD. Regarding particular issues like the necessity for shock efficacy testing, or the clinical outcome as compared to transvenous ICD, randomized data are expected in the near future.",

keywords = "Consensus, Death, Sudden, Cardiac/prevention & control, Defibrillators, Implantable, Humans",

author = "Christoph Schukro and David Santer and G{\"u}nther Prenner and Markus St{\"u}hlinger and Martin Martinek and Alexander Teubl and Deddo Moertl and Stefan Schwarz and Michael N{\"u}rnberg and Lukas Fiedler and Robert Hatala and Cesar Khazen",

note = "Publisher Copyright: {\textcopyright} 2020 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.",

year = "2020",

month = oct,

day = "1",

doi = "10.1002/clc.23432",

language = "English",

volume = "43",

pages = "1084--1092",

journal = "Clinical Cardiology",

issn = "0160-9289",

publisher = "John Wiley and Sons Inc.",

number = "10",

}

TY - JOUR

T1 - State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy

AU - Schukro, Christoph

AU - Santer, David

AU - Prenner, Günther

AU - Stühlinger, Markus

AU - Martinek, Martin

AU - Teubl, Alexander

AU - Moertl, Deddo

AU - Schwarz, Stefan

AU - Nürnberg, Michael

AU - Fiedler, Lukas

AU - Hatala, Robert

AU - Khazen, Cesar

PY - 2020/10/1

Y1 - 2020/10/1

N2 - Within the last decade, implantable cardioverter-defibrillator (ICD) systems with non-transvenous leads were developed in order to minimize complications related to the cardiovascular position of transvenous ICD leads. This national expert consensus gives an overview of potential indications for the implantation of non-transvenous ICD systems, and provides specific recommendations for implantation, follow-up, and complication management in patients with subcutaneous ICD. Regarding particular issues like the necessity for shock efficacy testing, or the clinical outcome as compared to transvenous ICD, randomized data are expected in the near future.

AB - Within the last decade, implantable cardioverter-defibrillator (ICD) systems with non-transvenous leads were developed in order to minimize complications related to the cardiovascular position of transvenous ICD leads. This national expert consensus gives an overview of potential indications for the implantation of non-transvenous ICD systems, and provides specific recommendations for implantation, follow-up, and complication management in patients with subcutaneous ICD. Regarding particular issues like the necessity for shock efficacy testing, or the clinical outcome as compared to transvenous ICD, randomized data are expected in the near future.

KW - Consensus

KW - Death, Sudden, Cardiac/prevention & control

KW - Defibrillators, Implantable

KW - Humans

UR - http://www.scopus.com/inward/record.url?scp=85089375436&partnerID=8YFLogxK

U2 - 10.1002/clc.23432

DO - 10.1002/clc.23432

M3 - Review article

C2 - 32794309

SN - 0160-9289

VL - 43

SP - 1084

EP - 1092

JO - Clinical Cardiology

JF - Clinical Cardiology

IS - 10

ER -

State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this